4//SEC Filing
STEYER THOMAS F 4
Accession 0000872574-18-000003
CIK 0001645666other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 9:28 PM ET
Size
11.0 KB
Accession
0000872574-18-000003
Insider Transaction Report
Form 4
STEYER THOMAS F
Other
Transactions
- Conversion
Common Stock
2018-06-25+210,326→ 210,326 total(indirect: By Trust) - Conversion
Common Stock
2018-06-25+125,927→ 125,927 total(indirect: By Trust) - Conversion
Series A Convertible Preferred Stock
2018-06-25−210,326→ 0 total(indirect: By Trust)→ Common Stock (210,326 underlying) - Conversion
Series B Convertible Preferred Stock
2018-06-25−125,927→ 0 total(indirect: By Trust)→ Common Stock (125,927 underlying)
Footnotes (1)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0000872574
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 9:28 PM ET
- Size
- 11.0 KB